Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

July 01, 1992; Volume 42,Issue 1
  • You have access
    Pharmacological characteristics of alpha 2-adrenergic receptors: comparison of pharmacologically defined subtypes with subtypes identified by molecular cloning.
    D B Bylund, H S Blaxall, L J Iversen, M G Caron, R J Lefkowitz and J W Lomasney
    Molecular Pharmacology July 1992, 42 (1) 1-5;
  • You have access
    Selective interaction of beta 2- and alpha 2-adrenergic receptors with stimulatory and inhibitory guanine nucleotide-binding proteins.
    Y Ogino, C M Fraser and T Costa
    Molecular Pharmacology July 1992, 42 (1) 6-9;
  • You have access
    Molecular structure and pharmacological characterization of humEAA2, a novel human kainate receptor subunit.
    R K Kamboj, D D Schoepp, S Nutt, L Shekter, B Korczak, R A True, D M Zimmerman and M A Wosnick
    Molecular Pharmacology July 1992, 42 (1) 10-15;
  • You have access
    Cloning of two mouse genes encoding alpha 2-adrenergic receptor subtypes and identification of a single amino acid in the mouse alpha 2-C10 homolog responsible for an interspecies variation in antagonist binding.
    R Link, D Daunt, G Barsh, A Chruscinski and B Kobilka
    Molecular Pharmacology July 1992, 42 (1) 16-27;
  • You have access
    Pharmacological properties of two cloned somatostatin receptors.
    S Rens-Domiano, S F Law, Y Yamada, S Seino, G I Bell and T Reisine
    Molecular Pharmacology July 1992, 42 (1) 28-34;
  • You have access
    Staurosporine-induced neurite outgrowth in PC12 cells is independent of protein kinase C inhibition.
    D Rasouly, E Rahamim, D Lester, Y Matsuda and P Lazarovici
    Molecular Pharmacology July 1992, 42 (1) 35-43;
  • You have access
    Molecular neurotoxicology of trimethyltin: identification of stannin, a novel protein expressed in trimethyltin-sensitive cells.
    S M Toggas, J K Krady and M L Billingsley
    Molecular Pharmacology July 1992, 42 (1) 44-56;
  • You have access
    Neutralization of bleomycin hydrolase by an epitope-specific antibody.
    G Morris, J S Mistry, J P Jani, J E Mignano, S M Sebti and J S Lazo
    Molecular Pharmacology July 1992, 42 (1) 57-62;
  • You have access
    Effect of antiinflammatory agents on synthesis of MCP-1/JE transcripts by human blood monocytes.
    M A Brach, H J Gruss, D Riedel, Y Asano, S De Vos and F Herrmann
    Molecular Pharmacology July 1992, 42 (1) 63-68;
  • You have access
    Expression of c-fos in human and murine multidrug-resistant cells.
    A Bhushan, R Abramson, J F Chiu and T R Tritton
    Molecular Pharmacology July 1992, 42 (1) 69-74;
  • You have access
    Gender-related expression of rat microsomal epoxide hydrolase during maturation: post-transcriptional regulation.
    S G Kim and Y H Kim
    Molecular Pharmacology July 1992, 42 (1) 75-81;
  • You have access
    Affinity alkylation of hamster hepatic arylamine N-acetyltransferases: isolation of a modified cysteine residue.
    H G Cheon, L W Boteju and P E Hanna
    Molecular Pharmacology July 1992, 42 (1) 82-93;
  • You have access
    Identification of amino acid residues of 5-lipoxygenase-activating protein essential for the binding of leukotriene biosynthesis inhibitors.
    P J Vickers, M Adam, S Charleson, M G Coppolino, J F Evans and J A Mancini
    Molecular Pharmacology July 1992, 42 (1) 94-102;
  • You have access
    Relaxation of pig coronary arteries by new and potent cGMP analogs that selectively activate type I alpha, compared with type I beta, cGMP-dependent protein kinase.
    K R Sekhar, R J Hatchett, J B Shabb, L Wolfe, S H Francis, J N Wells, B Jastorff, E Butt, M M Chakinala and J D Corbin
    Molecular Pharmacology July 1992, 42 (1) 103-108;
  • You have access
    Characterization of opioid receptors mediating stimulation of adenylate cyclase activity in rat olfactory bulb.
    M C Olianas and P Onali
    Molecular Pharmacology July 1992, 42 (1) 109-115;
  • You have access
    Beta-adrenergic receptor levels and function after growth of S49 lymphoma cells in low concentrations of epinephrine.
    M A Proll, R B Clark, T J Goka, R Barber and R W Butcher
    Molecular Pharmacology July 1992, 42 (1) 116-122;
  • You have access
    Chemical modification and irreversible inhibition of striatal A2a adenosine receptors.
    K A Jacobson, G L Stiles and X D Ji
    Molecular Pharmacology July 1992, 42 (1) 123-133;
  • You have access
    Existence and alpha 1-adrenergic stimulation of inositol polyphosphates in mammalian heart.
    J Scholz, U Troll, P Sandig, W Schmitz, H Scholz and J Schulte Am Esch
    Molecular Pharmacology July 1992, 42 (1) 134-140;
  • You have access
    Axoplasmic transport of [3H]ouabain binding sites and catecholamine secretion from an adrenergic nerve trunk.
    S Calvo, C González-García and V Ceña
    Molecular Pharmacology July 1992, 42 (1) 141-146;
  • You have access
    Up-regulation of N-methyl-D-aspartate receptors on cultured cortical neurons after exposure to antagonists.
    K Williams, M A Dichter and P B Molinoff
    Molecular Pharmacology July 1992, 42 (1) 147-151;
  • You have access
    Tunicamycin increases desensitization of junctional and extrajunctional acetylcholine receptors expressed in Xenopus oocytes by a mechanism independent of N-glycosylation blocking.
    T Nishizaki and K Sumikawa
    Molecular Pharmacology July 1992, 42 (1) 152-156;
  • You have access
    Spermine and related polyamines produce a voltage-dependent reduction of N-methyl-D-aspartate receptor single-channel conductance.
    D M Rock and R L MacDonald
    Molecular Pharmacology July 1992, 42 (1) 157-164;
  • You have access
    Characterization of bicuculline/baclofen-insensitive gamma-aminobutyric acid receptors expressed in Xenopus oocytes. I. Effects of Cl- channel inhibitors.
    R M Woodward, L Polenzani and R Miledi
    Molecular Pharmacology July 1992, 42 (1) 165-173;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 42, Issue 1
1 Jul 1992
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics